跟著怡琳看世界 11
Johnson & Johnson Covid vaccine: FDA approves single-shot jab
嬌生新冠疫苗:美國食藥署核准“只打一劑”
Regulator 監管單位
Cost-effective 有成本效益的/划算的
Jab 刺/注射
Moderate 減輕/主持
Scheme 計畫
US regulators have formally approved the single-shot Johnson & Johnson (J&J) coronavirus vaccine, the third jab to be authorised in the country.
美國監管單位正式核准只需打一劑的嬌生新冠疫苗，是該國核准的第三款疫苗。
The vaccine is set to be a cost-effective alternative to the Pfizer and Moderna vaccines, and can be stored in a refrigerator instead of a freezer.
這款疫苗被認定為相較於輝瑞及莫德納疫苗成本效益較高的選擇，並只需存於冰箱而非冷凍庫。
Trials found it prevented serious illness but was 66% effective overall when moderate cases were included.
臨床試驗顯示它可以防止嚴重身體不適，但包含較輕症狀在內有效力只達66%。
The company has agreed to provide the US with 100 million doses by the end of June.
該公司承諾在六月底前提供美國1億劑疫苗。
The UK, EU and Canada have also ordered doses, and 500 million doses have also been ordered through the Covax scheme to supply poorer nations.
英國、歐盟和加拿大也已經訂購疫苗，另外還有5億劑是透過全球疫苗取得機制訂購，要提供給較貧困國家。
